Muscat: Pfizer and BioNTech announced the third dose of the vaccine against COVID-19 is 95.6% effective in combating symptomatic disease.
“ A joint statement by Pfizer and BioNTech: The third dose of the vaccine against COVID-19 is 95.6% effective in combating symptomatic disease and has shown high safety, according to clinical trials that included 10,000 people over 16 years of age,” Oman TV News said in a statement.
